Ratings of the last 12 months
This list shows every rating MEQIRI has published for a stock, an ETF or a coin, and every change between Strong, Neutral and Weak. For stocks it also shows every valuation signal and its changes.
Counted from the public launch on 7 Nov 2026.
- Price target: none, MEQIRI does not give price targets.
- Fair value: for the valuation signal, that day's fair value, converted like the price. An estimate from the disclosed model, not a price target.
- Validity: until the rating or the valuation signal changes, time horizon about 12 months, recalculated every night.
- Price: last close before publication, converted into dollars at that day's ECB rate; ETFs in euros.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
6 entries
- Surgery Partners, Inc.12 Nov 2026Valuation signal Undervalued (Before Fairly valued), Fair value not meaningful, $26.66
- Surgery Partners, Inc.11 Nov 2026Neutral (Before Weak), Score 50, $26.73
- Surgery Partners, Inc.10 Nov 2026Weak (Before Neutral), Score 49, $26.45
- Surgery Partners, Inc.10 Nov 2026Valuation signal Fairly valued (Before Undervalued), Fair value not meaningful, $26.45
- Surgery Partners, Inc.7 Nov 2026Neutral (first rating), Score 51, $23.20
- Surgery Partners, Inc.7 Nov 2026Valuation signal Undervalued (first signal), Fair value not meaningful, $23.20
| Date | Security | Rating | Before | Score | Fair value | Price |
|---|---|---|---|---|---|---|
| 12 Nov 2026 | Surgery Partners, Inc. SGRY | Valuation signalUndervalued | Fairly valued | not meaningful | $26.66 | |
| 11 Nov 2026 | Surgery Partners, Inc. SGRY | Neutral | Weak | 50 | $26.73 | |
| 10 Nov 2026 | Surgery Partners, Inc. SGRY | Weak | Neutral | 49 | $26.45 | |
| 10 Nov 2026 | Surgery Partners, Inc. SGRY | Valuation signalFairly valued | Undervalued | not meaningful | $26.45 | |
| 7 Nov 2026 | Surgery Partners, Inc. SGRY | Neutral | first rating | 51 | $23.20 | |
| 7 Nov 2026 | Surgery Partners, Inc. SGRY | Valuation signalUndervalued | first signal | not meaningful | $23.20 |
Legal basis: Article 4(1)(i) of Delegated Regulation (EU) 2016/958.
To the disclosures